Chairman, Oyster Point Pharmaceuticals, Inc.; Chairman, Tarsus Pharmaceuticals, Inc.; CEO, Presidio Medical, Inc.
CEO, Tarusus Pharmaceuticals
Managing Partner & Founder, Longitude Capital
CEO, Equinox; Ophthalmologist, Vance Thompson Vision
Founder and Former CEO, Visiometrics
VP, Ocular Surface Disease, Johnson & Johnson Vision
VP Medical Devices, Ora, Inc.
Publisher, Retina Today
President and CEO, Glaukos
Senior VP, Corporate Development, Ora, Inc.
Founder, Charles Retina Institute
Partner, Flying-L Partners
Co-founder, ConnectOnCall; Partner, Long Island Vitreoretinal Consultants
Worldwide President, Surgical, Johnson & Johnson Vision
CEO, Vortex Surgical
Former CEO, Santen
Founder, Haffey & Co.
Global Head Retina & Glaucoma, Alcon
President, SafeCo, LLC
Vice-Chair Translational Research and Chief, Glaucoma Service, University of Colorado Eye Center
CEO, RxSight, Inc.
Founder, Retina and Vitreous of Texas; Board Member, LVX System
President & COO, Equinox
Global President, Ophthalmic Devices, Carl Zeiss Meditec
Co-founder, CEO, FundRx
President & CEO, Oyster Point Pharma
Co-Founder and CEO, Treehouse Eyes
COO, Sight Sciences
Former CEO, Notal Vision
Senior VP of Commercial Strategy and Operations, REGENXBIO
Co-Founder & Former CEO, Ophthotech
Global General Manager, Aviana Molecular Technologies
Sr. VP Corporate Strategy and Business Development, Glaukos
Partner, ExSight Ventures, Sr. Partner, Retina-Vitreous Associates Medical Group
Founder, Chairman, CTO, BroadSpot Imaging Corp.; Partner, Bay Area Retina
CEO, LensGen, Inc.
Partner, Protean, LLC
President & Chairman, Istylla; Chairman, Ocular Therapeutix
CEO, Katalyst Surgical; Chairman, Kogent Surgical
Sr. VP and Chief Commercial Officer, Ora, Inc.
VP Retina, Surgical & Upstream Marketing, Allergan
Former CEO, TLC Vision
Managing Partner, Visionary Venture Fund
Founder, Omega Ophthalmics; Ophthalmologist, Commonwealth Eye Surgery
President & CEO, Avedro
CEO, Oculus Surgical, Inc.